Quality-of-Life-Adjusted Survival Analysis of High-Dose Adjuvant Interferon Alfa-2b for High-Risk Melanoma Patients Using Intergroup Clinical Trial Data
- 1 March 2002
- journal article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 20 (5) , 1311-1318
- https://doi.org/10.1200/jco.20.5.1311
Abstract
No abstract availableThis publication has 0 references indexed in Scilit: